|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Ra Pharmaceuticals, Inc. (RARX) |
|
|
$46.96 0.00 (0.00%) as of 4:30 Thu 3/19
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
47,150,000 |
| Market
Cap: |
2.21(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$46.96 - $46.96 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Read Simon |
Chief Scientific Officer |
• – – |
2019-11-14 |
4 |
OE |
$2.87 |
$28,700 |
D/D |
10,000 |
16,234 |
|
- |
|
| Ricardo Alonso |
See Remarks |
• – – |
2019-10-17 |
4 |
AS |
$46.70 |
$106,710 |
D/D |
(2,285) |
6,858 |
|
- |
|
| Read Simon |
Chief Scientific Officer |
• – – |
2019-10-16 |
4 |
AS |
$46.87 |
$468,726 |
D/D |
(10,000) |
6,234 |
|
- |
|
| Read Simon |
Chief Scientific Officer |
• – – |
2019-10-16 |
4 |
OE |
$2.87 |
$28,700 |
D/D |
10,000 |
16,234 |
|
- |
|
| Farzaneh-Far Ramin |
Chief Medical Officer |
• – – |
2019-10-15 |
4 |
AS |
$46.89 |
$496,769 |
D/D |
(10,595) |
7,132 |
|
- |
|
| Farzaneh-Far Ramin |
Chief Medical Officer |
• – – |
2019-10-15 |
4 |
OE |
$5.60 |
$59,332 |
D/D |
10,595 |
17,727 |
|
- |
|
| Farzaneh-Far Ramin |
Chief Medical Officer |
• – – |
2019-09-16 |
4 |
AS |
$25.26 |
$267,675 |
D/D |
(10,595) |
7,132 |
|
- |
|
| Farzaneh-Far Ramin |
Chief Medical Officer |
• – – |
2019-09-16 |
4 |
OE |
$5.60 |
$59,332 |
D/D |
10,595 |
17,727 |
|
- |
|
| Read Simon |
Chief Scientific Officer |
• – – |
2019-09-12 |
4 |
AS |
$25.41 |
$254,050 |
D/D |
(10,000) |
6,234 |
|
- |
|
| Read Simon |
Chief Scientific Officer |
• – – |
2019-09-12 |
4 |
OE |
$2.87 |
$28,700 |
D/D |
10,000 |
16,234 |
|
- |
|
| Farzaneh-Far Ramin |
Chief Medical Officer |
• – – |
2019-08-23 |
4 |
AS |
$27.77 |
$294,226 |
D/D |
(10,595) |
7,132 |
|
- |
|
| Farzaneh-Far Ramin |
Chief Medical Officer |
• – – |
2019-08-23 |
4 |
OE |
$5.60 |
$59,332 |
D/D |
10,595 |
17,727 |
|
- |
|
| Ricardo Alonso |
See Remarks |
• – – |
2019-08-23 |
4 |
AS |
$27.89 |
$63,740 |
D/D |
(2,285) |
9,143 |
|
- |
|
| Read Simon |
Chief Scientific Officer |
• – – |
2019-08-23 |
4 |
AS |
$27.77 |
$277,703 |
D/D |
(10,000) |
6,234 |
|
- |
|
| Read Simon |
Chief Scientific Officer |
• – – |
2019-08-23 |
4 |
OE |
$2.87 |
$28,700 |
D/D |
10,000 |
16,234 |
|
- |
|
| Read Simon |
Chief Scientific Officer |
• – – |
2019-07-17 |
4 |
AS |
$32.95 |
$329,479 |
D/D |
(10,000) |
6,234 |
|
- |
|
| Read Simon |
Chief Scientific Officer |
• – – |
2019-07-17 |
4 |
OE |
$2.87 |
$28,700 |
D/D |
10,000 |
16,234 |
|
- |
|
| Farzaneh-Far Ramin |
Chief Medical Officer |
• – – |
2019-07-15 |
4 |
AS |
$32.97 |
$350,647 |
D/D |
(10,595) |
7,132 |
|
- |
|
| Farzaneh-Far Ramin |
Chief Medical Officer |
• – – |
2019-07-15 |
4 |
OE |
$5.60 |
$59,332 |
D/D |
10,595 |
17,727 |
|
- |
|
| Ricardo Alonso |
See Remarks |
• – – |
2019-06-21 |
4 |
AS |
$23.72 |
$67,782 |
D/D |
(2,857) |
11,428 |
|
- |
|
| Read Simon |
Chief Scientific Officer |
• – – |
2019-06-18 |
4 |
AS |
$22.21 |
$222,467 |
D/D |
(10,000) |
6,234 |
|
- |
|
| Read Simon |
Chief Scientific Officer |
• – – |
2019-06-18 |
4 |
OE |
$2.87 |
$28,700 |
D/D |
10,000 |
16,234 |
|
- |
|
| Farzaneh-Far Ramin |
Chief Medical Officer |
• – – |
2019-06-17 |
4 |
AS |
$21.41 |
$231,384 |
D/D |
(10,595) |
7,132 |
|
- |
|
| Farzaneh-Far Ramin |
Chief Medical Officer |
• – – |
2019-06-17 |
4 |
OE |
$5.60 |
$59,332 |
D/D |
10,595 |
17,727 |
|
- |
|
| King John C |
Chief Commercial Officer |
• – – |
2019-04-16 |
4 |
D |
$21.93 |
$98,817 |
D/D |
(4,506) |
10,823 |
|
- |
|
148 Records found
|
|
Page 2 of 6 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
